日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response

新辅助化疗前后卵巢癌的多组学特征分析揭示了肿瘤发生和化疗反应的介质

Valentine, Mark C; Mullen, Mary M; Kotnik, Emilee N; Powell, Matthew A; Thaker, Premal H; McCourt, Carolyn K; Kuroki, Lindsay M; Hagemann, Andrea R; Arend, Rebecca C; Holehouse, Alex S; Mitra, Robi; Mutch, David G; Fuh, Katherine C

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.

磷酸化RPA2可预测同源重组功能正常的卵巢癌对铂类和PARP抑制剂的反应

Schab Angela, Compadre Amanda, Drexler Rebecca, Loeb Megan, Rodriguez Kevin, Brill Joshua, Harrington Shariska, Sandoval Carmen, Sanders Brooke, Kuroki Lindsay, McCourt Carolyn, Hagemann Andrea R, Thaker Premal, Mutch David, Powell Matthew, Serra Violeta, Hagemann Ian S, Walts Ann E, Karlan Beth Y, Orsulic Sandra, Fuh Katherine C, Sun Lulu, Verma Priyanka, Lomonosova Elena, Zhao Peinan, Khabele Dineo, Mullen Mary M

DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells

DDR2赋予癌相关成纤维细胞铁死亡抵抗力,并减弱卵巢肿瘤细胞对PARP抑制剂的敏感性

Lesage, Julien; DiMauro, Alessandra; Schab, Angela M; Stidham, Seth; Mullen, Mary M; Fuh, Katherine C; Longmore, Gregory D

Real-world outcomes after pembrolizumab treatment for cervical cancer: Results from a university setting

帕博利珠单抗治疗宫颈癌的真实世界疗效:来自大学环境的研究结果

Furuya, Rachel L; Boak, Katelin; Mullen, Mary M; Wang, Dong; Massad, L Stewart

Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms

靶向 COP9 信号体可通过两种不同的基因组稳定性机制克服卵巢癌的铂类耐药性。

Lomonosova, Elena; Loeb, Megan; Rodriguez, Kevin; van Biljon, Lilian N; Brill, Joshua; Schab, Angela; Minett, Margaret; Barron, Jaeden; Bittner, Maya; Park, Jiyoung; Drexler, Rebecca; Sandoval, Carmen; Oplt, Alyssa; Gallup, Eden; Thuthika, Prasanth K; Sadeghipour, Negar; Wu, Sharon; Oberley, Matthew J; Sanders, Brooke; Kuroki, Lindsay; McCourt, Carolyn; Hagemann, Andrea R; Thaker, Premal; Mutch, David; Powell, Matthew; Hagemann, Ian S; Ilagan, Ma Xenia G; Fuh, Katherine; Verma, Priyanka; Schärer, Orlando D; Mosammaparast, Nima; Khabele, Dineo; Mullen, Mary M

Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancers

靶向ALC1可以安全地扩大PARP抑制剂在高级别浆液性卵巢癌中的治疗应用范围。

Aubuchon, Lindsey N; Wong, Deanna H; Ramakrishnan, Natasha M; Reddy, Rohan; Compadre, Amanda; Lomonosova, Elena; Jackson, Kathleen E; Kemper, Danielle; Mehta, Vrutti; Zoberi, Kellen; Khabele, Dineo; Christie, Elizabeth L; Mullen, Mary M; Verma, Priyanka

A toolkit for a modern gynecologic oncology tissue bank

现代妇科肿瘤组织库工具包

Graham, Olivia; Rodriguez, Jeimmy; Abbott, Rachel; Lomonosova, Elena; Fashemi, Bisiayo; Drexler, Rebecca; Grither, Whitney; Rodriguez, Kevin; Compadre, Amanda; Loeb, Megan; Sanders, Brooke; Kuroki, Lindsay; Hagemann, Andrea R; McCourt, Carolyn; Thaker, Premal H; Fuh, Katherine; Powell, Matthew A; Hagemann, Ian S; Mutch, David G; Khabele, Dineo; Mullen, Mary M

Prophylactic antibiotics for excision of premalignant vulvar lesions: A pilot randomized controlled trial

预防性使用抗生素治疗外阴癌前病变切除术:一项初步随机对照试验

Mullen, Mary M; Grither, Whitney R; Millimet, Hannah; Mutch, David G; Hagemann, Andrea R; McCourt, Carolyn K; Powell, Matthew A; H Thaker, Premal; Khabele, Dineo; Kuroki, Lindsay M

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival

对原发性和转移性高级别浆液性卵巢癌肿瘤的基因特征分析揭示了与生存相关的独特特征

Kotnik, Emilee N; Mullen, Mary M; Spies, Nicholas C; Li, Tiandao; Inkman, Matthew; Zhang, Jin; Martins-Rodrigues, Fernanda; Hagemann, Ian S; McCourt, Carolyn K; Thaker, Premal H; Hagemann, Andrea R; Powell, Matthew A; Mutch, David G; Khabele, Dineo; Longmore, Gregory D; Mardis, Elaine R; Maher, Christopher A; Miller, Christopher A; Fuh, Katherine C

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis.

AVB-500 通过抑制 GAS6-AXL 来降低肿瘤细胞糖酵解,从而克服子宫内膜癌对紫杉醇的耐药性

Bruce Shaina F, Cho Kevin, Noia Hollie, Lomonosova Elena, Stock Elizabeth C, Oplt Alyssa, Blachut Barbara, Mullen Mary M, Kuroki Lindsay M, Hagemann Andrea R, McCourt Carolyn K, Thaker Premal H, Khabele Dineo, Powell Matthew A, Mutch David G, Shriver Leah P, Patti Gary J, Fuh Katherine C